Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan 1:16:1536012116689001.
doi: 10.1177/1536012116689001.

Image-Based Analysis of Tumor Localization After Intra-Arterial Delivery of Technetium-99m-Labeled SPIO Using SPECT/CT and MRI

Affiliations

Image-Based Analysis of Tumor Localization After Intra-Arterial Delivery of Technetium-99m-Labeled SPIO Using SPECT/CT and MRI

In Joon Lee et al. Mol Imaging. .

Abstract

The aim of this study is to evaluate the localization of 99mTc-labeled dextran-coated superparamagnetic iron oxide (SPIO) nanoparticles to the liver tumor using image-based analysis. We delivered 99mTc-SPIO intravenously or intra-arterially (IA) with/without Lipiodol to compare the tumor localization by gamma scintigraphy, single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI) in a rabbit liver tumor. The gamma and SPECT image-based analysis shows that the uptake ratio of the tumor to the normal liver parenchyma is highest after delivery of 99mTc-SPIO with Lipiodol IA and that well correlates with the trend of the signal decrease in the liver MRIs. Intra-arterial delivery of SPIO with Lipiodol might be a good drug delivery system targeting the hepatic tumors, as confirmed by image-based analysis.

Keywords: Intra-arterial (IA) delivery; magnetic resonance imaging (MRI); single-photon emission computed tomography (SPECT); superparamagnetic iron oxide (SPIO); technetium-99m.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Overview of the experimental design.
Figure 2.
Figure 2.
The surface modification and 99mTc labeling of SPIO: The schematic procedure for the surface modification of SPIO and 99mTc labeling (A); the size distribution of the SPIO, the modified SPIO, and the 99mTc-SPIO (B); radiochromatograms of 99mTc-SPIO (C). SPIO indicates superparamagnetic iron oxide.
Figure 3.
Figure 3.
A, Tumor localization images of 99mTc-SPIO: Gamma scintigraphy and SPECT MIP (maximum intensity projection); (B) Pre-contrast CT; (C) SPECT/CT; (D) T2*-weighted images pre- or postdelivery of 99mTc-SPIO. CT indicates computed tomography; SPECT, single-photon emission computed tomography; SPIO, superparamagnetic iron oxide.
Figure 4.
Figure 4.
The image-based analysis of tumor localization of 99mTc-SPIO. A, The uptake ratio of the tumor to the normal liver parenchyma on the 99mTc-SPIO SPECT/CT at 90 minutes after delivery (positive results [P < .05] in the post hoc test: A vs B [P = .032], A vs C [P = .032], B vs C [P = .043]. B, The uptake ratio of tumors to the normal liver parenchyma on the 99mTc-SPIO scintigraphy images after 180 minutes. CT indicates computed tomography; SPECT, single-photon emission computed tomography; SPIO, superparamagnetic iron oxide.
Figure 5.
Figure 5.
Signal decreases of the tumor on second MRIs at 3 hours after delivery (first MRIs: gray bar; second MRIs: dark gray bar; positive results in the post hoc test for second MRIs: A vs C (P < .001), B vs C (P < .001). MRI indicates magnetic resonance imaging.
Figure 6.
Figure 6.
Photograph of Prussian blue staining: ×200 image in group A. A, There is no Prussian blue–positive vesicles in the tumor, ×200 images in group B. B, Prussian blue–positive vesicles (blue color) are deposited in the septum (circle) and the tumor cell (arrow), ×200 image in group C. C, Prussian blue–positive vesicles (blue color) is frequently demonstrated around occluded tumor vessels filled with blood clots (stars), ×400 image in normal liver parenchyma. D, A small cell (arrow head) suggested Kupffer cell contains Prussian blue–positive vesicles (blue color).

Similar articles

Cited by

References

    1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90. - PubMed
    1. Kim YI, Park JW, Kwak HW, et al. Long-term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma. Liver Int. 2014;34(8):1278–1286. - PubMed
    1. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208–1236. - PubMed
    1. Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255. - PubMed
    1. Chung JW, Kim HC, Yoon JH, et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma: prevalence and causative factors of extrahepatic collateral arteries in 479 patients. Korean J Radiol. 2006;7(4):257–266. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources